Results 1 to 10 of about 24,950 (282)
Finasteride Side Effects and Post-Finasteride Syndrome in Male Androgenic Alopecia [PDF]
Journal of Mind and Medical Sciences, 2015 Finasteride is in present a relatively frequent prescribed drug for male androgenic alopecia. The adverse effects reported by some patients seem to be notable, consisting of various (physical, mental/ neurological, sexual, etc.) manifestations which are ...
Manea Mirela +3 more
doaj +3 more sources
Finasteride for hair loss: a review
Journal of Dermatological Treatment, 2022 Background and Objectives Finasteride 1 mg/day is indicated for androgen-dependent conditions such as male androgenetic alopecia (AGA). Methods The literature is comprehensively summarized on the pharmacodynamics, pharmacokinetics, mechanism of action ...
exaly +3 more sources
Clinical Interventions in Aging, 2019 Zhongbao Zhou,1,2,* Shiqiang Song,3,* Zhenli Gao,2 Jitao Wu,2 Jiajia Ma,2 Yuanshan Cui2 1School of clinical medicine, Binzhou Medical University, Yantai, Shandong, China; 2Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao ...
Z Zhou +5 more
core +4 more sources
Indian Dermatology Online Journal, 2015 Background: Finasteride acts by reducing dihydrotestosterone levels, thereby inhibiting miniaturization of hair follicles in patients with androgenetic alopecia (AGA).
B S Chandrashekar +4 more
doaj +2 more sources
Androgenic alopecia; the risk–benefit ratio of Finasteride
Journal of Mind and Medical Sciences, 2018 Finasteride is currently approved and largely used as a therapeutic option for androgenetic alopecia. Apparently a safe drug and effective at the onset, several concerns appeared over time regarding the frequency and magnitude of finasteride adverse ...
David L. Rowland +6 more
doaj +4 more sources
Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial. [PDF]
PLoS ONE, 2015 OBJECTIVE:In the Prostate Cancer Prevention Trial (PCPT), finasteride reduced the risk of prostate cancer by 25%, even though high-grade prostate cancer was more common in the finasteride group.
Cindy H Chau +15 more
doaj +3 more sources
Finasteride in the treatment of clinical benign prostatic hyperplasia: A systematic review of randomised trials [PDF]
BMC Urology, 2002 Background Benign prostatic hyperplasia affects older men. This systematic review determined efficacy and adverse effects of finasteride. Review methods PubMed, the Cochrane Library, reference lists of reports, and reviews were searched for randomised ...
Moore R Andrew, Edwards Jayne E
doaj +2 more sources
Finasteride adverse effects and post-finasteride syndrome; implications for dentists
Journal of Mind and Medical Sciences, 2016 Finasteride is a 5α-reductase inhibitor widely used in present in the therapeutic approach of androgenic alopecia. Adverse effects consist in variable sign and symptoms, the most common being represented by mental troubles (reduced feeling of life ...
Stana Paunica +7 more
doaj +2 more sources
Post-finasteride syndrome: our current knowledge
Вестник урологии, 2020 5-α reductase inhibitors are effective and commonly used medications for the treatment of benign prostatic hyperplasia. However, there are some questions about the safety of such medications.
A. A. Galushkin +2 more
doaj +3 more sources
Chinese Medical Journal. Background:. Topical finasteride is a novel treatment for men with androgenetic alopecia (AGA). This study aimed to evaluate the efficacy and safety of topical finasteride spray solution in Chinese men with AGA. Methods:. This randomized, double-blind,
Cheng Zhou +19 more
doaj +2 more sources